Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-01
1999-10-19
Fan, Jane
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D40104
Patent
active
059691441
ABSTRACT:
The present invention is directed to radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. These radiolabeled epibatidine compounds are used to noninvasively image and quantify nicotinic cholinergic receptors in the living brain for both research studies and the diagnosis of neurodegenerative diseases.
REFERENCES:
patent: 3932429 (1976-01-01), Takeda et al.
patent: 4499099 (1985-02-01), Watts
patent: 4985063 (1991-01-01), Fischer et al.
patent: 5015655 (1991-05-01), Galliani et al.
patent: 5314899 (1994-05-01), Daly et al.
patent: 5462956 (1995-10-01), Daly et al.
CA 123: 246612, Houghtling et al., 1995.
CA 122: 309826, Alane et al., 1995.
CA 120: 77489, Corey et al., 1993.
CA 120: 315194, Badio et al., 1994.
Badio et al., Epibatidine, a Potent Analgetic and Nicotinic Agonist; Molecular Pharmacology, 45:563-56 (1994).
Dagami, Ron, Cocaine Analog for Parkinsonism Studies, Chem& Eng. News, pp. 25-26, Oct. 14, 1991.
Horti et al., Chemical Abstracts, 125:11186, 1996.
Imaging Alzheimer's, Science, 266:1810, Dec. 16, 1994.
Laruelle, Marc, et al., SPECT Imaging of Dopamine and Serotonin Tramporters with [1231]-2.beta.-CIT Pharmacological Characterization of Brain Uptake in Nonhuman Primates, Synapse, 13: 295-309, (1993).
London et al., Nicotinic Binding Sites in Cerebral Cortex and Hippocampus in Alzheimer's Dementia Neurochemical Research, 14:745-750 (1989).
London et al., In vivo labeling of nicotinic acetylcholine receptors in brain With [.sup.3 H]epibatidine; Europea Journal of Pharmacology, 278 (1995) R1-R2.
Lundykvist, Camilia et al., [O-Methyl-.sup.11 C].beta.-CIT-FP, a Potential Radioligand for Quantitation of th Dopamine Transporter: Preparation, Autoradiography, Metabolite Studies, and Positron Emissio Tomography Examinations, Nucl. Med. Biol., 22:905-913 (1995).
Neumeyer, John L., et al., [.sup.123 I]-2.beta.-Carbomethoxy-3.beta.-(r-iodophenyl)tropane: High-Affinity SPEC Radiotracer of Monoamine Reuptake Sites In Brain, J. Med. Chem., 34:3144-3146 (1991).
Nyback et al., Attempts to visualize nicotine receptors in the brain of monkey and man by positron emissio tomography; Progress In Brain Research, Nordberg et al. (ED.), 79:313-19 (1989).
Patt et al., [.sup.11 C]-N-methyl- and [.sup.18 F] fluoroethylepibatidine: Ligands for the Neuronal Nicotinic Receptor Journal of Labelled Compounds and Radiopharmaceuticals, 37: 355-56 (1995)(abstract only).
Siebyl, John P., et al., Reproducibility of Iodine-123-.beta.-CIT SPECT Brain Measurement of Dopamin Transporters, J. of Nuclear Med., 37:222-228, (1996).
Warpman et al., Chemical Abstracts, 124:199570, 1996.
Dannals Robert F.
Horti Andrew
Kassiou Michael
Kimes Alane S.
London Edythe D.
Fan Jane
The United States of America as represented by the Department of
LandOfFree
Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057190